Requests that the FDA undertake the following specific administrative actions within the Agency's statutory authority. (1) Issue guidance instructing the United States Pharmacopeia to develop Biological Product Specifications for each licensed biologic, employing validated non-proprietary analytical methods, standardized product release specifications, certified reference materials,
🏛 Food and Drug Administration (FDA)FDA-2025-P-6763
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.